TFAP2A通过增强AOC1转录来促进NSCLC恶性进展
Xiang Miao1, Hongzhen Zheng1, Huimin Mo1
1Department of Pulmonary and Critical Care Medicine, Shidong Hospital of Yangpu District, No. 999, Shiguang Road, Yangpu District, Shanghai, 200438, China.
沉默转录因子AP-2α (TFAP2A) 通过调节氨酸氧化酶含铜1 (AOC1) 转录来抑制非小细胞肺癌 (NSCLC) 的进展. 这种AOC1/TFAP2A通路为NSCLC治疗提供了潜在的治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 非小细胞肺癌 (NSCLC) 的死亡率很高,患者结局变化不定.
- 含铜的氨基氧化酶1 (AOC1) 和转录因子AP-2α (TFAP2A) 被认为是各种瘤中的瘤基因.
- 了解AOC1和TFAP2A在NSCLC中的作用对于开发向疗法至关重要.
研究的目的:
- 研究AOC1和TFAP2A对非小细胞肺癌 (NSCLC) 进展的影响.
- 在NSCLC中阐明TFAP2A和AOC1之间的监管关系.
- 探索针对AOC1/TFAP2A轴进行NSCLC治疗的潜力.
主要方法:
- 在NSCLC患者数据中对AOC1和TFAP2A表达的生物信息分析.
- 定量实时聚合酶连锁反应 (RT-qPCR) 和西部斑点来评估基因和蛋白质水平.
- 在体外测试细胞增殖,迁移,亡,线粒体膜潜力和ROS.
- 在体内研究使用裸体小鼠皮下移植瘤.
- 染色体免疫沉 (CHIP) 和 luciferase 记者基因测定以确认TFAP2A-AOC1结合.
主要成果:
- 在NSCLC组织和细胞系中观察到高AOC1和TFAP2A表达.
- 通过AOC1的淘汰,抑制了NSCLC细胞的增殖,迁移,M2巨分极和线粒体膜潜能,同时促进了亡和ROS.
- 在体内,AOC1沉默抑制了瘤生长.
- 发现TFAP2A通过转录调节来增强AOC1的表达,从而促进NSCLC的进展.
结论:
- TFAP2A通过转录上调AOC1表达来促进NSCLC的进展.
- 针对TFAP2A-AOC1通路为NSCLC提供了一个有前途的治疗策略.
- 沉默TFAP2A通过调节AOC1转录来有效抑制NSCLC的进展.
更多相关视频
07:38Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
10:32Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs
Published on: December 19, 2019
相关概念视频
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Abnormal Proliferation
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
